4.6 Review

Faecalibacterium prausnitzii and human intestinal health

Journal

CURRENT OPINION IN MICROBIOLOGY
Volume 16, Issue 3, Pages 255-261

Publisher

CURRENT BIOLOGY LTD
DOI: 10.1016/j.mib.2013.06.003

Keywords

-

Categories

Funding

  1. Vitagora Competitive Cluster
  2. French FUI (Fond Unique Interministeriel
  3. FUI) [F1010012D]
  4. FEDER (Fonda Europeen de Developpement Regional
  5. Bourgogne) [34606]
  6. Burgundy Region
  7. Conseil General 21
  8. Grand Dijon
  9. Merck Medication Familiale (Dijon, France)
  10. Biovitis (Saint Etienne de Chomeil, France)

Ask authors/readers for more resources

Faecalibacterium prausnitzii is the most abundant bacterium in the human intestinal microbiota of healthy adults, representing more than 5% of the total bacterial population. Over the past five years, an increasing number of studies have clearly described the importance of this highly metabolically active commensal bacterium as a component of the healthy human microbiota. Changes in the abundance of F. prausnitzii have been linked to dysbiosis in several human disorders. Administration of F. prausnitzii strain A2-165 and its culture supernatant have been shown to protect against 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced colitis in mice. Here, we discuss the role of F. prausnitzii in balancing immunity in the intestine and the mechanisms involved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available